5 completed, 2 terminated, 1 withdrawn. 3 Phase 4, 2 Not applicable, 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 1, Terminated 1, Withdrawn 1 |
| Not applicable | 2 | Completed 2 |
| Phase 2 | 2 | Completed 1, Terminated 1 |
| Phase 1 | 1 | Terminated 1 |
Follow lepirudin: new trials by email Literature Review of lepirudin trials Research Report on lepirudin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase II Growth and Safety Study of an Infant Formula for Healthy Term Infants BBN, Brand - Infant Development | Not applicable | Completed | Building Block Nutritionals, LLC | 131 | 2020-10-14 | 2021-11-15 |
| Growth and Safety Study of an Infant Formula for Healthy Term Infants BBN, Brand - Infant Development | Not applicable | Completed | Building Block Nutritionals, LLC | 260 | 2017-09-18 | 2020-10-19 |
| Pharmacokinetic Studies of Tacrolimus in Transplant Patients Prograf, Tacrolimus - Kidney Transplant Recipients, Liver Transplant Recipients | Phase 4 | Completed | University of Cincinnati | 78 | 2013-06-01 | 2016-02-22 |
| Retrospective Registry of Patients With Acute Heparin-induced Thrombocytopenia Type II lepirudin, danaparoid, argatroban - Acute HIT II (Heparin-induced Thrombocytopenia Type II) | Completed | GlaxoSmithKline | 195 | 2009-02-01 | 2017-07-06 | |
| Argatroban Versus Lepirudin in Critically Ill Patients Argatroban, Lepirudin - Heparin Induced Thrombocytopenia (HIT) | Phase 4 | Terminated | Heinrich-Heine University, Duesseldorf | 70 | 2009-01-01 | 2012-06-21 |
| Fondaparinux in Patients With Acute Heparin-Induced Thrombocytopenia (HIT) fondaparinux, argatroban or lepirudin - Heparin-Induced Thrombocytopenia | Phase 4 | Withdrawn | Methodist Healthcare - Memphis | 2008-01-01 | 2019-08-13 | |
| Heparin Versus Lepirudin Flushes in Preventing Blockage of Venous Access Devices Lepirudin - Thrombosis | Phase 2 | Completed | National Institutes of Health Clinical Center (CC) | 340 | 2002-05-01 | 2008-03-04 |
| Lepirudin in Treating Patients With Recurrent or Advanced Small Cell Lung Cancer lepirudin - Lung Cancer | Phase 1 / Phase 2 | Terminated | Dartmouth-Hitchcock Medical Center | 1 | 1998-11-01 | 2016-08-08 |
Lung Neoplasms (1) · Small Cell Lung Carcinoma (1) · Thrombocytopenia (1) · Thrombosis (1)
Building Block Nutritionals, LLC (2) · Dartmouth-Hitchcock Medical Center (1) · GlaxoSmithKline (1) · Heinrich-Heine University, Duesseldorf (1) · Methodist Healthcare - Memphis (1) · National Institutes of Health Clinical Center (CC) (1) · University of Cincinnati (1)
United States (5) · Germany (1)
Bob L Lobo, Pharm.D. (1) · James R. Rigas, MD (1) · Kumar Ilangovan, MD (1) · Laurie Dunn, MD (1) · Peter Kienbaum, MD (1) · Rita R Alloway, PharmD, FCCP (1) · Sohail Minhas, MD (1)
PMID 24840511, PMID 25344113, PMID 29135993, PMID 29169470, PMID 29426286, PMID 33314078, PMID 41406156
P30CA023108 (1)